Navigation Links
To accept or not accept -- Patients want a say in liver transplant decisions
Date:7/15/2014

A novel study reveals that more than half of liver transplant patients want to be informed of donor risk at the time a liver is offered for transplantation. Nearly 80% of those patients want to be involved in the decision of whether or not to accept the organ according to findings published in Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

There is a shortage of available donor organs, which leaves many on the liver transplant waiting list. Currently, there are more than 16,000 patients in need of a liver in the U.S., according to the Organ Procurement and Transplantation Network (OPTN). While the use of extended criteria donors increases available organs, it comes with higher donor-related risks compared to a standard criteria donor. Medical evidence shows discussions with transplant candidates regarding donor-related risk vary from country to country.

"Donor-related risks such as disease transmission and graft failure are weighed against the patient's risk of remaining on the waiting list," explains Dr. Robert Porte from the University Medical Center Groningen in The Netherlands. "While active patient decision making and donor-specific risk have been discussed in the medical literature, our study is the first to report the opinions of liver patients on these issues."

For the present study the team surveyed 40 liver transplant candidates and 179 patients who received liver transplants at the University Medical Center between 2000 and 2010. The study group was primarily middle-aged, Dutch men. Between 60% and 75% of the patients wanted to be informed of donor-related risk, with 53% of the group preferring to be informed of these risks at the time of organ offer. Of these patients, 80% wanted to be involved in deciding to accept the organ or not, 11% wished to make the final decision alone and 10% did not want to be invo
'/>"/>

Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Poorly-performing hand implants unacceptable says leading medical journal
2. HF/E researchers examine older adults willingness to accept help from robots
3. Cystic fibrosis patients of low SES are less likely to be accepted for lung transplant
4. Paid Diabetes Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, Alabama; Accepting M/F Age 18+ with Type 2 Diabetes
5. Texas Clinic Now Accepting Brachial Plexus Patients; Children and Adults
6. MileageAds Online Advertising Network Now Accepting Publishers and Advertisers
7. People Seem More Accepting of Food Addiction Than Other Vices
8. The Woodlands, TX Periodontist, Dr. Gayle Bradshaw is Now Accepting New Patients For The Modern Bone Graft Procedure To Strengthen Jaw Bone For Dental Implants
9. Beautologie Plastic Surgery Now Accepts Insurance Plans for Breast Reduction Surgery
10. eHealth Thought Leadership Forum Accepting New Council Members
11. Ashkin Predicts 2013 Will Be Tipping Point for Climate Change Acceptance
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
To accept or not accept -- Patients want a say in liver transplant decisions
(Date:10/22/2014)... With the Affordable Care Act (ACA) open enrollment period starting ... Research (AIR) finds that three out of four Americans are ... percent say they are not likely or only somewhat likely ... , The AIR survey found wide gaps in Americans’ health ... how much they owe for a routine doctor’s visit. , ...
(Date:10/22/2014)... Losing Weight Your Body’s Way , In a world where ... it certainly can be difficult to choose the right weight ... by doing it the healthy way? Set aside the fads ... body, exercise regularly, and choose foods with the most nutritional ... need to exercise more and eat less. Despite the number ...
(Date:10/22/2014)... Akeso Biomedical, Inc. , a privately held ... infections, microbial biofilms, and chronic wounds, announced that Dr. ... , Dr. Sinskey is a Professor ... of Technology, or MIT. He has been a member ... holds positions as Co-Director of the Malaysia-MIT Biotechnology Partnership ...
(Date:10/22/2014)... By Tara Haelle ... -- Binge drinking among young adult men may lead to ... binge drinking didn,t cause a similar rise in blood pressure ... study. In fact, when young adult women drank lightly or ... half, the study found. "This finding parallels studies in ...
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter ... was diagnosed with Ebola while working for NBC News ... leave the special isolation unit at Nebraska Medical Center in Omaha, ... hospital said Tuesday. A blood test confirmed by the U.S. ... can head home to Providence, R.I., NBC News reported ...
Breaking Medicine News(10 mins):Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3
... in the war on asthma symptom control could be a ... that Mom and Dads leeriness towards their childrens asthma medications ... health risks that outweigh the benefits might explain to ... children with the wheezing, coughing and trouble-breathing disease do not ...
... Consultech Strengthens Omnicom,s Presence in China,s Growing ... ... Omnicom Group Inc.,("Omnicom") (NYSE: OMC ), the leading global ... Services,division ("DAS"), a majority ownership interest in Consultech, a leading,healthcare ...
... The American,Psychiatric Association (APA) applauds the U.S. Food and ... led to the,approval of a new treatment for two ... the approvals are a result of the federal,Best Pharmaceuticals ... that leads to this kind of approval, given that ...
... 180 day shared exclusivity on the product, ... announced today that the Company has received tentative ... manufacture and market,Galantamine Hydrobromide Tablets, 4mg (base), 8mg ... treatment of mild to moderate dementia of,the Alzheimer,s ...
... the best drug treatment for their disease, because family doctors ... in the Archives of Disease in Childhood. , Around ... disease prompts up to a third of children aged between ... researchers used national data to calculate the number of prescriptions ...
... in This Region,Deep Commitment to this Market Evidenced in Opening of ... ... and PHILADELPHIA, Sept. 3 Rohm,and Haas Company (NYSE: ROH ... in India to meet,growing demand for its environmentally advanced products and ...
Cached Medicine News:Health News:Parents' perceptions can hamper kids' asthma care, study finds 2Health News:Parents' perceptions can hamper kids' asthma care, study finds 3Health News:Omnicom Acquires Leading Healthcare Marketing Communications Firm in China 2Health News:Omnicom Acquires Leading Healthcare Marketing Communications Firm in China 3Health News:APA Comments on FDA's First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder 2Health News:Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis 2Health News:Childhood asthma still inappropriately treated in the UK 2Health News:Rohm and Haas Expands in India 2Health News:Rohm and Haas Expands in India 3Health News:Rohm and Haas Expands in India 4
(Date:10/22/2014)... Oct. 21, 2014   BioNano Genomics , ... genomics research centers to purchase an Irys™ System ... National Cancer Institute (NCI), NIH Intramural Sequencing Center (NISC) ... Irys, obtaining a comprehensive view of a genome ... (NGS) does not deliver the scalability or reliability ...
(Date:10/22/2014)... InVivo Therapeutics Holdings Corp. (OTCQB: NVIV) based ... spinal cord injury (SCI) treatment with their novel Neuro-Spinal ... tissue regrowth in the spinal cord area when cells ... approved polymer, the scaffold ultimately breaks down to water ... body. NVIV has recently attracted significant investor attention with ...
(Date:10/22/2014)... 2014  AcelRx Pharmaceuticals, Inc. (NASDAQ: ... IAP310 study have been published in Regional ... journal with broad, multidisciplinary readership. IAP310 was a ... and efficacy of Zalviso, also referred to as ... treatment of post-operative pain in patients following open ...
Breaking Medicine Technology:BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results 2
... policy , , ROCHESTER, Minn., ... use of the drug therapy etanercept ineffective in treating alcoholic hepatitis, ... alcohol. The results of the study are published in the December ... , VIDEO ALERT: Additional audio and video ...
... VICL ) announced today the receipt of a $1.0 ... Merck,s planned initiation of a Phase I clinical trial of ... is based on Vical,s DNA gene delivery technology and encodes ... separate license agreement. , , ...
Cached Medicine Technology:Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2
... precise and accurate Measurements! ,Patients are impressed ... examination when they see the doctor is ... - after only 5 minutes of proper ... proficient in the operation of this instrument ...
Great for small incisions and excision needs...
Ideal for short scleral tunnel and trabecular meshwork incisions...
30 Pre-formed and razor sharp...
Medicine Products: